课题基金 / 基金详情

Coenzyme F420, helping mycobacteria find a niche in humans

Coenzyme F420, helping mycobacteria find a niche in humans
辅酶 F420,帮助分枝杆菌在人类中找到一席之地
批准号:
10666639
负责人:
Michael Berney
金额:
$19.8万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-07-15 至 2024-06-30

项目摘要

项目成果

Michael Berney的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Project summary Mycobacterium tuberculosis, the causative agent of TB, remains an important cause of morbidity and mortality worldwide. Persistence in hypoxic conditions within granuloma is the hallmark of TB, leading to latent infection and limiting the application of current therapies. Understanding how M. tuberculosis supports its metabolism under hypoxic conditions, and adapts to these challenges, is key to eliminating latent TB. “Disarming” M. tuberculosis by removing its ability to endure the stress-inducing conditions in granuloma will provide a feasible strategy for clinical interventions against latent TB. We will investigate the role of the coenzyme F420 in the physiology and pathogenesis of M. tuberculosis. F420 is a deazaflavin that acts as a carrier in a wide range of hydride transfer reactions. Growing evidence points to the wide use of this cofactor by M. tuberculosis, with its low redox potential thought to give it key roles in hypoxic persistence. There appears to be F420-dependent mechanisms in mycobacteria that are used to protect against oxidative and nitrosative stress, but the contribution of F420 to M. tuberculosis metabolism and persistence remains unclear. The ultimate goal of the project is to investigate how F420 facilitates M. tuberculosis’ survival under hypoxic conditions within granuloma, elucidating its role in persistence. We have devised an integrated experimental approach using genetics, metabolomics, animal infection models, and protein biochemistry tools to determine how F420 helps M. tuberculosis persist during pathogenesis. We will construct a set of conditional knockdown strains targeting F420 biosynthesis and metabolism, and perform in vitro studies to determine how M. tuberculosis utilizes F420 under hypoxic conditions and during re-growth after hypoxia-induced dormancy. We will then perform infection studies in a mouse model that develops necrotic and hypoxic TB lesions to investigate how F420 facilitates M. tuberculosis survival inside granuloma and to understand the link between F420 and persistence. Finally, we will reveal structural insights into the biosynthesis of F420 chromophore, providing the foundations for mechanistic and inhibition studies of this essential reaction in F420 biosynthesis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The PDIM paradox of M. tuberculosis
Identification of new inhibitors of essential functions in M. tuberculosis by high-throughput metabolic profiling
Coenzyme F420, helping mycobacteria find a niche in humans
Eradicating persistent M. tuberculosis by synthetic lethality of terminal respiratory oxidases
海外基金